UK markets closed
NIKKEI 225
27,518.25 +41.38 (+0.15%) HANG SENG
19,784.65 +216.96 (+1.11%) CRUDE OIL
73.58 +0.77 (+1.06%) GOLD FUTURES
1,975.30 +21.50 (+1.10%) DOW
32,394.25 -37.83 (-0.12%) Bitcoin GBP
22,065.11 +71.83 (+0.33%)
Enzo Biochem, Inc. (0IHV.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 06:44PM BST
| Previous close | 2.1940 |
| Open | 2.3150 |
| Bid | 0.0000 x N/A |
| Ask | 0.0000 x N/A |
| Day's range | 2.3080 - 2.3150 |
| 52-week range | 2.3080 - 2.3150 |
| Volume | |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | 0.88 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.1400 |
| Earnings date | 07 Jun 2023 - 12 Jun 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Enzo Biochem Second Quarter 2023 Earnings: US$0.23 loss per share (vs US$0.055 loss in 2Q 2022)
Enzo Biochem ( NYSE:ENZ ) Second Quarter 2023 Results Key Financial Results Revenue: US$16.3m (down 52% from 2Q 2022...
- Simply Wall St.
Following a 26% decline over last year, recent gains may please Enzo Biochem, Inc. (NYSE:ENZ) institutional owners
Key Insights Institutions' substantial holdings in Enzo Biochem implies that they have significant influence over the...
- Simply Wall St.
Is Enzo Biochem (NYSE:ENZ) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
© 2023 Yahoo. All rights reserved.
